Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

Document and Entity Information

Document and Entity Information
12 Months Ended
Dec. 31, 2019
Document and Entity Information [Abstract]  
Entity Registrant Name Aurinia Pharmaceuticals Inc.
Entity Central Index Key 0001600620
Document Type 40-F
Amendment Flag false
Document Period End Date Dec. 31, 2019
Current Fiscal Year End Date --12-31
Document Fiscal Year Focus 2019
Document Fiscal Period Focus FY
Entity Current Reporting Status Yes
Entity Emerging Growth Company false
Entity Common Stock, Shares Outstanding 111,798,275